NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Alkermes plc (NASDAQ: ALKS) concerning possible violations of federal securities laws.
On November 6, 2017, it was announced that an investigation has commenced concerning Alkermes’ sales practices for Vivitrol. In particular, Senator Kamala Harris said the Company had “aggressively marketed” Vivitrol and contributed to “misconceptions about other medications used in the fight to combat the opioid epidemic...” To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171122005626/en/
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq., 212-363-7500
Toll Free: 877-363-5972
Source: Levi & Korsinsky, LLP